This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD tool for common mental health disorders administered by health care professionals. The PHQ-2 inquires about the frequency of depressed mood, with a score ranging from 0 to 6.
Provides an overview of the key points of the National Practice Guideline, detailed recommendations for OUD diagnosis, and information on treatment settings and opioid withdrawal. Describes MAT options and considerations for treating special populations. Links to additional resources, such as a pocket guide and a slide deck.
Highlights the use of MAT for opioid use disorder in drug courts, reviews effective medications, and provides strategies to increase the use of MAT in drug court programs.
MCPAP for Moms provides obstetricians, midwives, and PCPs with psychiatric consultation for behavioral health concerns and questions around medications when pregnant or breastfeeding. MCPAP for Moms also supports connections with community-based services and support groups.
This documents designed for treatment providers in behavioral health programs to support clients at risk for or diagnosed with hepatitis C.
This page provides motivational techniques and skills for health and mental health coaching/counseling.
Offers clinicians information on medications for opioid addiction treatment, including side effects, drug interactions, and take-home doses. Discusses patient counseling, associated medical problems, hepatitis C evaluation, drug testing, and pregnant women.
Email Updates